Issuance of stock acquisition rights for directors and executive officers
First written in FY2017-Q3. 6 of 8 entries say "Advanced", first in FY2018-Q3. Latest entry: FY2025.
- FY2025AdvancedAnnual report
「Other items for the fiscal year consisted of grants of restricted stock (103,100 shares; total disposal value: ¥146 million) and exercise of share acquisition rights (69,900 shares; total disposal value: ¥99 million).」
The grant of restricted stock compensation and exercise of share acquisition rights progressed, with 103,100 restricted shares granted and 69,900 share acquisition rights exercised during the fiscal year. - FY2023AdvancedAnnual report
「Exercise of stock options (15,200 shares)」
During the fiscal year, 15,200 stock options for directors, executive officers and others were exercised. - FY2021AdvancedAnnual report
「The principal changes in treasury stock during the current consolidated fiscal year were an increase of 22 shares from the purchase of less-than-one-unit shares and a decrease of 163,500 shares from the exercise of stock options.」
During the current fiscal year, 163,500 shares were exercised under stock options for directors, executive officers, and others, resulting in the disposal of treasury stock. - FY2020-Q3AdvancedAnnual report
「Resolution date 6 November 2019 Categories and number of eligible recipients (people) Company directors 5 Company executive officers 10 Company senior officers 13 Number of stock acquisition rights (units)* 1,046 (Note 1) Number of shares underlying the stock acquisition rights (shares)* 104,600 (Note 1) Exercise period for the stock acquisition rights* 3 December 2019 to 2 December 2049」
A total of 1,046 stock acquisition rights covering 104,600 shares were newly issued for 5 directors, 10 executive officers, and 13 senior officers. - FY2019-Q3AdvancedAnnual report
「Resolution date 13 November 2018 Categories and number of eligible recipients (people) Company directors 5 Company executive officers 23 Number of stock acquisition rights (units)* 1,037 (Note 1) Number of shares underlying the stock acquisition rights* 103,700 (Note 1)」
A total of 1,037 stock acquisition rights covering 103,700 shares were newly issued for 5 directors and 23 executive officers. The exercise period was set from 4 December 2018 to 3 December 2048. - FY2018-Q3AdvancedAnnual report
「Resolution date 13 November 2017 Number of stock acquisition rights (units) 602 (Note 1) Number of shares underlying the stock acquisition rights 60,200 (Note 1)」
Based on the resolution of 13 November 2017, 602 stock acquisition rights covering 60,200 shares were newly issued for directors and executive officers. - FY2017RestatedAnnual report
「Based on the resolution of the Board of Directors dated 10 November 2016, 1,187 stock acquisition rights covering 118,700 shares had been issued as of 31 March 2017.」
This restates the issuance record for stock acquisition rights granted to directors and executive officers and the exercise period from December 2016 to December 2046. - FY2017-Q3First statedAnnual report
「Eligible recipients of the stock acquisition rights may exercise those rights only during the period from the day after they cease to hold the position of director or executive officer of the Company through the day on which 10 days have elapsed, within the period from 2 December 2016 to 1 December 2046.」
Based on the resolution of 10 November 2016, 1,187 stock acquisition rights covering 118,700 shares were issued. The eligible recipients were directors and executive officers, and the exercise period was set from 2 December 2016 to 1 December 2046.